XEBIO Holdings CO., LTD. (8281) AI Stock Analysis

• Market Cap: ¥48.32B
• Dividend Yield: 3.23%
• Average Volume (3M): 153.55K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.28
• Revenue Growth: 1.82%
• EPS Growth: -148.67%
• Country: JP
• Employees: 2,560
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Specialty Retail
• EPS (TTM): 6.96
• Shares Outstanding: 47,911,022
• 10 Day Avg. Volume: 94,160
• 30 Day Avg. Volume: 153,553
• PEG Ratio: -0.93
• Price to Book (P/B): 0.46
• Price to Sales (P/S): 0.22
• P/FCF Ratio: 10.46
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 60 Neutral
• Price Target: ¥1,166.00 ▲(7.47% Upside)

XEBIO Holdings' stock score is primarily influenced by its strong financial position and revenue growth. However, technical indicators point to bearish momentum, and the negative P/E ratio raises concerns about profitability. The attractive dividend yield provides some support, but overall caution is advised.

XEBIO Holdings CO., LTD. Business Overview & Revenue Model

Company Description

XEBIO Holdings CO., LTD. (8281) is a Japan-based retail company primarily engaged in the sale of sporting goods and apparel. The company operates through various brands and stores, focusing on providing a wide range of products for sports enthusiasts, including footwear, clothing, and equipment. XEBIO also emphasizes e-commerce and online sales to enhance customer accessibility and satisfaction. Its operations span across multiple sectors within the sporting goods industry, positioning the company as a key player in the market.

How the Company Makes Money

XEBIO Holdings generates revenue primarily through the retail sales of sporting goods and apparel across its physical stores and online platforms. The company benefits from a diverse product range, which includes popular sports brands and proprietary labels, allowing for competitive pricing and customer loyalty. Significant revenue streams include in-store sales, e-commerce transactions, and seasonal promotional events. Additionally, XEBIO may engage in partnerships with sports organizations and sponsorships, further enhancing brand visibility and customer engagement, which contribute positively to its overall earnings.

XEBIO Holdings CO., LTD. Financial Statement Overview

Summary

XEBIO Holdings shows consistent revenue growth and a strong balance sheet with low leverage. However, profitability is moderate, and capital expenditures impact free cash flow ratios.

Income Statement

XEBIO Holdings has shown consistent revenue growth with a 3.37% increase in the latest year. Gross and net profit margins are healthy at 36.8% and 0.39% respectively, though the latter indicates some room for improvement in profitability. EBIT and EBITDA margins are at 2.8% and 3.64%, showing moderate operational efficiency.

Balance Sheet

The company maintains a strong financial position with a Debt-to-Equity ratio of 0.06, suggesting low leverage. A Return on Equity (ROE) of 0.8% highlights potential for increased profitability. The equity ratio stands at 59.7%, indicating substantial equity financing, which is favorable.

Cash Flow

XEBIO Holdings has demonstrated significant improvement in free cash flow, transitioning from negative to positive, signifying better cash management. The operating cash flow to net income ratio is strong at 12.42, reflecting robust cash generation relative to net income, though free cash flow to net income is lower, indicating CAPEX impacts.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	249.77B	250.60B	242.43B	239.29B	223.28B	202.44B
Gross Profit	97.23B	92.23B	92.89B	91.77B	87.05B	78.82B
EBITDA	5.62B	9.11B	9.72B	12.97B	9.25B	7.68B
Net Income	-1.53B	971.00M	2.59B	5.40B	3.84B	412.00M
Balance Sheet
Total Assets	212.61B	203.96B	209.53B	211.30B	208.31B	207.48B
Cash, Cash Equivalents and Short-Term Investments	22.07B	19.86B	24.94B	32.89B	39.89B	44.32B
Total Debt	7.26B	7.37B	9.95B	12.63B	15.18B	15.43B
Total Liabilities	91.22B	81.83B	84.72B	88.73B	89.60B	91.13B
Stockholders Equity	121.00B	121.72B	124.45B	122.36B	118.66B	116.31B
Cash Flow
Free Cash Flow	0.00	5.31B	-2.86B	1.38B	-2.78B	20.13B
Operating Cash Flow	0.00	12.06B	4.27B	7.02B	2.23B	25.37B
Investing Cash Flow	0.00	-9.60B	-8.04B	-5.48B	-5.16B	-2.02B
Financing Cash Flow	0.00	-7.53B	-4.14B	-7.91B	-2.12B	8.51B

XEBIO Holdings CO., LTD. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1085.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8281, the sentiment is Negative. The current price of 1085 is below the 20-day moving average (MA) of 1107.75, below the 50-day MA of 1125.45, and below the 200-day MA of 1160.84, indicating a bearish trend. The MACD of -13.52 indicates Positive momentum. The RSI at 41.28 is Neutral, neither overbought nor oversold. The STOCH value of 11.32 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:8281.

XEBIO Holdings CO., LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9832	75 Outperform	¥118.93B	11.99	7.75%	3.81%	17.43%	248.12%
7419	74 Outperform	¥344.73B	8.64	―	1.14%	15.92%	52.76%
7545	65 Neutral	¥127.40B	14.95	―	1.52%	3.95%	2.75%
2678	64 Neutral	$126.39B	16.96	10.61%	2.68%	1.69%	-57.32%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
8282	61 Neutral	¥239.57B	21.95	―	2.96%	2.23%	57.10%
8281	60 Neutral	¥48.32B	-29.19	―	3.23%	1.82%	-148.67%

XEBIO Holdings CO., LTD. Corporate Events

XEBIO Finalizes Stock-Based Compensation for Directors

XEBIO Holdings Co., Ltd. has finalized the allotment of stock acquisition rights as stock-based compensation for its directors, a decision made during the Board of Directors meeting on August 19, 2025. This move involves the issuance of 18,900 common shares and is part of the company’s strategy to align director incentives with shareholder interests, potentially impacting its governance and financial strategies.

The most recent analyst rating on (JP:8281) stock is a Hold with a Yen1216.00 price target. To see the full list of analyst forecasts on XEBIO Holdings CO., LTD. stock, see the JP:8281 Stock Forecast page.

XEBIO Holdings Aligns Director Compensation with Performance through Stock Options

XEBIO Holdings Co., Ltd. announced the issuance of stock acquisition rights as stock-based compensation for its directors, excluding outside directors. This move is intended to align directors’ compensation with the company’s performance and enhance their motivation for long-term growth. The initiative involves issuing 189 units of stock acquisition rights, with each right entitling the holder to 100 common shares, and is priced using the Black-Scholes model.

XEBIO Holdings Reports Decline in Q1 2025 Financial Performance

XEBIO Holdings reported a decline in financial performance for the three months ending June 30, 2025, with net sales decreasing by 1.3% and profit attributable to owners of the parent plummeting by 89.6% compared to the same period last year. The company forecasts a modest recovery in net sales and operating profit for the fiscal year ending March 31, 2026, despite the challenging financial results in the first quarter.